A thyroid FNA (fine needle aspiration) is a biopsy that uses a thin needle to extract cells from a thyroid nodule so they can be examined under a microscope for signs of cancer. It’s the most reliable non-surgical way to determine whether a thyroid nodule is benign or malignant, with an overall sensitivity of about 87% and specificity around 73%. The procedure is quick, usually performed in a doctor’s office, and most people return to normal activities the same day.
Why Doctors Recommend an FNA
Thyroid nodules are extremely common, and the vast majority are harmless. Finding a nodule on an ultrasound doesn’t automatically mean you need a biopsy. Doctors decide based on two factors: how suspicious the nodule looks on ultrasound and how large it is.
Nodules that appear highly suspicious (irregular borders, tiny calcifications, taller-than-wide shape) are typically biopsied once they reach 1 centimeter. Nodules that look moderately suspicious have a higher threshold, usually 1.5 centimeters. Low-suspicion nodules, those with smooth borders and a mostly fluid-filled appearance, may not be biopsied until they reach 2 to 2.5 centimeters. Nodules that look completely benign on imaging generally don’t need a biopsy at all, regardless of size.
What Happens During the Procedure
You’ll lie on your back with your neck slightly extended, sometimes with a pillow beneath your shoulders. The doctor performs a quick ultrasound to locate the nodule, map nearby blood vessels, and plan the needle path. The skin over your neck is cleaned and draped, and a small amount of local anesthetic may be injected to numb the area, though some practitioners skip this since the biopsy needle itself is so thin (roughly the same gauge used for a routine blood draw).
Using real-time ultrasound guidance, the doctor inserts a fine needle through the skin and into the nodule. The needle is moved back and forth several times within the nodule to collect cells. In some cases, gentle suction from an attached syringe helps draw cells into the needle; in others, the cells enter the needle through capillary action alone. This process is repeated several times, usually with separate needle passes, until enough tissue has been collected. A pathologist may review the sample on-site to confirm it’s adequate before you leave.
The entire procedure typically takes 15 to 30 minutes, including preparation. The needle insertions themselves last only seconds each.
Ultrasound Guidance vs. Palpation
Older techniques involved feeling the nodule by hand and inserting the needle without imaging. Ultrasound guidance has largely replaced this approach because it produces far fewer inadequate samples. In one comparison, 27% of palpation-guided biopsies didn’t collect enough cells to make a diagnosis, versus only 13% with ultrasound guidance. That difference matters because an inadequate sample means repeating the procedure. Today, ultrasound-guided FNA is the standard at most centers.
Understanding Your Results
Thyroid FNA results are reported using the Bethesda System, a standardized six-category scale that tells you and your doctor how likely the nodule is to be cancerous.
- Category I: Nondiagnostic. The sample didn’t contain enough cells for evaluation. This happens in roughly 10 to 15% of biopsies. You’ll likely need a repeat FNA.
- Category II: Benign. About 1% chance of malignancy. This is the most common result, and it usually means monitoring the nodule with periodic ultrasounds rather than removing it.
- Category III: Atypia of undetermined significance. The cells look slightly unusual but aren’t clearly abnormal. The cancer risk is around 17%. Your doctor may recommend a repeat biopsy or molecular testing.
- Category IV: Suspicious for a follicular neoplasm. About 25% chance of malignancy. Surgery to remove part of the thyroid is often recommended, though molecular testing may help clarify the picture first.
- Category V: Suspicious for malignancy. Roughly 70% chance of cancer. Surgery is the typical next step.
- Category VI: Malignant. Cancer is confirmed in about 98% of cases. Treatment planning, usually surgery, begins promptly.
What Happens With Indeterminate Results
Categories III and IV are the gray zone. The cells don’t look clearly benign or clearly cancerous, which can feel frustrating. In the past, the main option was diagnostic surgery: removing part of the thyroid just to get a definitive answer. Today, molecular testing can often help avoid that surgery.
These tests analyze the genetic material in your biopsy sample, looking for DNA mutations, gene fusions, and expression patterns associated with thyroid cancer. Two of the most widely used are ThyroSeq, which scans over 100 genes for cancer-linked alterations, and Afirma GSC, which uses gene expression patterns to classify a nodule as suspicious or benign. A third approach combines a mutation panel with a microRNA classifier to assess risk from multiple angles.
If a molecular test comes back benign or low-risk, your doctor may recommend monitoring rather than surgery. If it comes back suspicious, surgery becomes more clearly warranted. These tests don’t replace a final surgical pathology diagnosis, but they give you and your doctor much better information for decision-making when the biopsy result falls in the middle.
Risks and Side Effects
Thyroid FNA is one of the safest biopsy procedures. The most common side effects are mild pain at the needle site and minor bruising. Small hematomas (collections of blood under the skin) occur in roughly 1 to 4% of cases, depending on the technique used. These typically resolve on their own within a few days.
Serious complications are rare. Significant bleeding, infection, and nerve injury are possible in theory but occur so infrequently that large studies struggle to calculate meaningful percentages for them. The thin gauge of the needle is the main reason: it’s small enough that it causes minimal tissue damage.
Preparation and Blood Thinners
There’s very little preparation required. You can eat and drink normally beforehand. The main consideration is blood-thinning medication. Because the needles used are so fine (22 to 25 gauge), many centers perform the biopsy without stopping anticoagulants at all. If you’re on warfarin and your doctor wants to minimize bruising, a 3 to 5 day hold may be recommended. The key point is to never stop a blood thinner on your own. Your prescribing doctor needs to weigh the clotting risk before making that call.
Recovery After the Biopsy
Recovery is minimal. You can return to normal activities, including work, the same day. MD Anderson Cancer Center recommends leaving the bandage on for four hours and keeping the area dry for 24 hours. Some people experience mild neck soreness or a small bruise for a day or two. Over-the-counter pain relief handles this for most people.
Results typically come back within a few days to a week, depending on the lab. If molecular testing is ordered on an indeterminate sample, those results may take an additional one to two weeks.